SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,247 | -25.4% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,731 | +0.6% | 2,953 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $13,643 | -43.4% | 2,953 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $24,086 | +45.6% | 2,981 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,545 | +742.4% | 2,981 | +690.7% | 0.00% | – |
| Q2 2022 | $1,964 | -91.9% | 377 | -87.2% | 0.00% | -100.0% |
| Q1 2022 | $24,224 | -83.4% | 2,947 | -70.0% | 0.00% | -50.0% |
| Q4 2021 | $146,315 | -39.1% | 9,833 | -22.6% | 0.00% | -33.3% |
| Q3 2021 | $240,092 | +7.3% | 12,710 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $223,656 | +13.8% | 12,031 | +39.3% | 0.00% | 0.0% |
| Q1 2021 | $196,601 | +4.8% | 8,638 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $187,531 | +116.0% | 8,638 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $86,812 | – | 8,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |